Literature DB >> 28257694

Thyroglobulin in Metastatic Thyroid Cancer: Culprit or Red Herring?

Lamis Yehia1, Ying Ni2, Charis Eng3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28257694      PMCID： PMC5339110          DOI： 10.1016/j.ajhg.2017.01.023

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  11 in total

1.  The BRAF V600E mutation predicts poor survival outcome in patients with papillary thyroid carcinoma: a meta analysis.

Authors:  Jianhua Li; Shuijun Zhang; Shouhua Zheng; Danhua Zhang; Xinguang Qiu
Journal:  Int J Clin Exp Med       Date:  2015-12-15

2.  BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.

Authors:  Mingzhao Xing; Rengyun Liu; Xiaoli Liu; Avaniyapuram Kannan Murugan; Guangwu Zhu; Martha A Zeiger; Sara Pai; Justin Bishop
Journal:  J Clin Oncol       Date:  2014-07-14       Impact factor: 44.544

3.  BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

Authors:  Mingzhao Xing; William H Westra; Ralph P Tufano; Yoram Cohen; Eli Rosenbaum; Kerry J Rhoden; Kathryn A Carson; Vasily Vasko; Alexandr Larin; Giovanni Tallini; Sara Tolaney; Elizabeth H Holt; Pei Hui; Christopher B Umbricht; Shehzad Basaria; Marge Ewertz; Anthony P Tufaro; Joseph A Califano; Matthew D Ringel; Martha A Zeiger; David Sidransky; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2005-09-20       Impact factor: 5.958

4.  Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.

Authors:  A J Herle; R P Uller
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

5.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

Review 6.  Clonal evolution in cancer.

Authors:  Mel Greaves; Carlo C Maley
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 7.  TERT promoter mutations in thyroid cancer.

Authors:  Rengyun Liu; Mingzhao Xing
Journal:  Endocr Relat Cancer       Date:  2016-01-05       Impact factor: 5.678

8.  Highly prevalent TERT promoter mutations in aggressive thyroid cancers.

Authors:  Xiaoli Liu; Justin Bishop; Yuan Shan; Sara Pai; Dingxie Liu; Avaniyapuram Kannan Murugan; Hui Sun; Adel K El-Naggar; Mingzhao Xing
Journal:  Endocr Relat Cancer       Date:  2013-07-12       Impact factor: 5.678

9.  The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.

Authors:  T Liu; N Wang; J Cao; A Sofiadis; A Dinets; J Zedenius; C Larsson; D Xu
Journal:  Oncogene       Date:  2013-10-21       Impact factor: 9.867

10.  TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.

Authors:  Miguel Melo; Adriana Gaspar da Rocha; João Vinagre; Rui Batista; Joana Peixoto; Catarina Tavares; Ricardo Celestino; Ana Almeida; Catarina Salgado; Catarina Eloy; Patrícia Castro; Hugo Prazeres; Jorge Lima; Teresina Amaro; Cláudia Lobo; Maria João Martins; Margarida Moura; Branca Cavaco; Valeriano Leite; José Manuel Cameselle-Teijeiro; Francisco Carrilho; Manuela Carvalheiro; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  J Clin Endocrinol Metab       Date:  2014-01-29       Impact factor: 5.958
View more
  1 in total

1.  Cancer classification based on chromatin accessibility profiles with deep adversarial learning model.

Authors:  Hai Yang; Qiang Wei; Dongdong Li; Zhe Wang
Journal:  PLoS Comput Biol       Date:  2020-11-09       Impact factor: 4.475
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.